Unexpected consequence of enterprise digital transformation on financial investments
Journal of Corporate Accounting & Finance · 2024-04 · 35 (2) · 121-134
DOI: 10.1002/jcaf.22674 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Corporate Accounting & Finance, online erschienen am 27.11.2023. Verfasst von Shiguang Li und 2 weiteren Autor:innen. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
Digital transformation provides new opportunities for companies, but also unexpected consequences. We quantify the firms’ level of digitalization using text analysis to examine whether digital transformation affects financial investment. The results conclude that digital transformation increases financial investment and our findings remain valid after robustness checks, indicating that digital transformation unexpectedly exacerbates the financialization problem of Chinese companies. We further discuss the motive and channels of corporate financialization under digital transformation. Our results show that digital transformation increases financial investment through financial surrogate intermediaries and higher return on financial assets. Therefore, managers should not ignore the potential negative effects during the process of digital transformation.
Zitieren
APA
Li, S., Yang, Z., & Tian, Y. (2024). Unexpected consequence of enterprise digital transformation on financial investments. Journal of Corporate Accounting & Finance, 35(2), 121-134. https://doi.org/10.1002/jcaf.22674
Vancouver
Li S, Yang Z, Tian Y. Unexpected consequence of enterprise digital transformation on financial investments. Journal of Corporate Accounting & Finance. 2024;35(2):121-134. doi:10.1002/jcaf.22674
BibTeX
@article{Li2024,
author = {Li, Shiguang and Yang, Zheng and Tian, Yixiang},
title = {Unexpected consequence of enterprise digital transformation on financial investments},
journal = {Journal of Corporate Accounting & Finance},
year = {2024},
volume = {35},
number = {2},
pages = {121--134},
doi = {10.1002/jcaf.22674}
}
EUVIMED